$FRX Recent Headlines U.S. stocks end choppy trade

New Post Public Reply Private Reply Replies (0) Message Board

May 20, 2014 at 9:44 AM

$FRX Recent Headlines

U.S. stocks end choppy trade higher 5:07 p.m. April 28, 2014 - Anora Mahmudova
Plug Power tanks on fuel-cell criticism; Pfizer gains 3:47 p.m. April 28, 2014 - Sue Chang
Health-care market rises on Merger Monday deals 11:52 a.m. April 28, 2014 - Russ Britt
Stock futures point to rise as drug stocks rally 9:29 a.m. April 28, 2014 - Anora Mahmudova
Forest Labs buys Furiex for $1.1 bln in cash 7:35 a.m. April 28, 2014 - Saumya Vaishampayan
Furiex surges 36% after acquisition by Forest 7:25 a.m. April 28, 2014 - Saumya Vaishampayan
Forest Labs buys Furiex for $1.1 bln in cash 7:24 a.m. April 28, 2014 - Saumya Vaishampayan
Richter, Forest bipolar-drug trial result positive 3:24 a.m. March 31, 2014 - MarketWatch.com
The 10 most overbought stocks in the S&P 500 index 12:19 p.m. March 25, 2014 - The Trading Deck
Forest Laboratories gains 2.7% to lead the S&P 500 9:31 a.m. March 24, 2014 - Sue Chang
Icahn Enterprises reports profit up 144% in 2013 11:23 a.m. March 3, 2014 - MarketWatch
Stocks rally; S&P 500 ends right below record 5:46 p.m. Feb. 24, 2014 - Victor Reklaitis
U.S. stock market is starting to ride a tech M&A wave 6:31 a.m. Feb. 24, 2014 - Wallace Witkowski
Smart Money sells into Mylan rise for a good reason 3:05 p.m. Feb. 20, 2014 - The Trading Deck
Actavis continues hot streak with better-than-expected earnings 12:21 p.m. Feb. 20, 2014 - Russ Britt
Actavis swings to loss on charges, write-downs 9:04 a.m. Feb. 20, 2014 - MarketWatch.com
Pharma megamergers bring higher profits, better returns, study says 2:59 p.m. Feb. 19, 2014 - Russ Britt
Actavis, Forest shares continue their climb in aftermath of $25 billion deal 12:03 p.m. Feb. 19, 2014 - Russ Britt
U.S. stocks edge up; Nasdaq gains for 8th day in a row 5:38 p.m. Feb. 18, 2014 - Anora Mahmudova
Forest Laboratories, Actavis surge on buyout deal 5:11 p.m. Feb. 18, 2014 - Sue Chang

Tracking Carl Icahn's Portfolio - Q1 2014 Update 1:46 a.m. Today - Seeking Alpha
Will This Price Target Increase Help Forest Laboratory (FRX) Stock Today? 9:18 a.m. May 19, 2014 - TheStreet.com
A Proud 'Dinosaur' of Stock Picking 11:44 a.m. May 16, 2014 - The Wall Street Journal Interactive Edition
J.P.Morgan's Geoff Meacham Plucks Biotechs With Upside From A Down Market 9:17 a.m. May 16, 2014 - Seeking Alpha
GuruFocus Guru of the 2013 Carl Icahn's Top First Quarter Holdings 6:34 p.m. May 15, 2014 - GuruFocus.com
Synergy Pharma Posts Narrower-than-Expected Q1 Loss - Analyst Blog 11:00 a.m. May 14, 2014 - Zacks.com
New leadership team at Actavis after Forest deal closes 9:56 a.m. May 14, 2014 - Seeking Alpha
Forest Labs' Saunders to Head Actavis When Deal Closes 8:55 a.m. May 14, 2014 - The Wall Street Journal Interactive Edition
Several meds may help break the alcohol habit 7:22 a.m. May 14, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – CAH PDLI SHPG FRX 2:00 p.m. May 13, 2014 - InvestorPlace.com
Cross-Border Megamergers Drive Global Takeover Boom 4:01 p.m. May 12, 2014 - Investors Business Daily
Antibiotics Approvals to Surge 7:06 a.m. May 12, 2014 - Barrons.com
M.D. Sass: Bullish on Broadcast, Health Care 3:26 a.m. May 10, 2014 - Barrons.com
International Guru Bernard Horn Reports His Top Five in the First Quarter 6:38 p.m. May 7, 2014 - GuruFocus.com
Mario Gabelli's GAMCO Investors Top 5 New Stocks 4:24 p.m. May 7, 2014 - GuruFocus.com
3 Stocks Pushing The Health Care Sector Lower 1:03 p.m. May 7, 2014 - TheStreet.com
Forest Laboratories Inc (FRX): Today's Featured Drugs Laggard 5:01 p.m. May 6, 2014 - TheStreet.com
Commit To Buy Forest Laboratories At $87.50, Earn 8.3% Annualized Using Options 11:36 a.m. May 5, 2014 - TheStreet.com
Health Care Stocks Still Healthy Despite Higher Hedging Costs 6:30 a.m. May 2, 2014 - TheStreet.com
A Look At World Stocks' Q1: Shire, Actavis, NXP Semi 4:32 p.m. May 1, 2014 - Investors Business Daily

Forest Laboratories, Inc. to Present Data about Aclidinium, Aclidinium/Formoterol Combination, and Roflumilast at the American Thoracic Society International Conference 4:05 p.m. May 16, 2014 - BusinessWire - BZX
Forest Laboratories, Inc. to Present Nebivolol/Valsartan Fixed-Dose Combination Data at the American Society of Hypertension Annual Scientific Meeting 4:05 p.m. May 16, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: Brower Piven Announces Class Action Lawsuit in Connection With the Sale of Furiex Pharmaceuticals, Inc. to Forest Laboratories, Inc. and Royal Empress, Inc. -- FURX 7:11 p.m. May 14, 2014 - GlobeNewswire
Actavis Announces Proposed Senior Leadership Team Effective Following Completion of Forest Laboratories Acquisition 8:00 a.m. May 14, 2014 - PR Newswire - PRF
RiverVest Venture Partners’ Portfolio Company Lumena is Sold to Shire for $260 million; Represents Sixth Exit from RiverVest Venture Fund II 10:39 a.m. May 12, 2014 - BusinessWire - BZX
Pharma Stocks Technical Briefing -- Research on Forest Laboratories, Valeant Pharma, IntelliPharmaCeutics Intl., and Acura Pharma 8:09 a.m. May 8, 2014 - PR Newswire - PRF
Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 6:32 p.m. May 7, 2014 - PR Newswire - PRF
Genetic Disorders Partnering Terms and Agreements 5:35 p.m. May 7, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT:Brower Piven Announces the Investigation of Furiex Pharmaceuticals, Inc. in Connection with the Proposed Sale of the Company to Forest Laboratories, Inc. 4:41 p.m. May 5, 2014 - BusinessWire - BZX
Former Forest Laboratories GC Joins Lowenstein Sandler's Life Sciences Practice 10:00 a.m. May 5, 2014 - PR Newswire - PRF
Actavis and Forest Announce Effectiveness of Registration Statement on Form S-4 9:02 a.m. May 5, 2014 - BusinessWire - BZX
Actavis and Forest Announce Effectiveness of Registration Statement on Form S-4 9:00 a.m. May 5, 2014 - PR Newswire - PRF
Earnings Results, Acquisitions, Drug Designations, Dividend Authorizations, and Licensing Agreements - Analyst Notes on AstraZeneca, Furiex, GW, Techne and Agenus 8:00 a.m. May 5, 2014 - PR Newswire - PRF
Quarterly Earnings Releases, Social Initiatives, and Upcoming Conferences - Analyst Notes on Merck, WellPoint, UnitedHealth, Forest and Celgene 8:00 a.m. May 5, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of Furiex Pharmaceuticals, Inc. Buyout 3:37 p.m. May 1, 2014 - BusinessWire - BZX
Ironwood and Forest to Present Linaclotide Data at Digestive Disease Week® 2014 8:31 a.m. May 1, 2014 - BusinessWire - BZX
Pfizer Expects $100 Billion Grab for AstraZeneca to Boost Pipeline and Drop Tax Rate, an Industrial Info News Alert 6:31 a.m. April 30, 2014 - Marketwire
Ryan & Maniskas, LLP Announces Investigation of Furiex Pharmaceuticals, Inc. 10:35 a.m. April 29, 2014 - PR Newswire - PRF
FURIEX SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Furiex Pharmaceuticals, Inc. (FURX) Over the Proposed Sale of the Company to Forest Laboratories, Inc. 8:25 p.m. April 28, 2014 - BusinessWire - BZX
Acquisition of Furiex Pharmaceuticals, Inc. by Forest Laboratories, Inc. May Not Be in Shareholders' Best Interests 6:57 p.m. April 28, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

IASLC Boosts Global Thoracic Cancer Collaboration

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

ARTiSTORY's Strategic Advance in Cultural IP Licensing

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Delhi Pushes Innovation Against Dryland Challenges

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

PathoSearch: A New Era in Pathology With Visual Search

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Countries Eye New Investment Paths at CIFIT 2026

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Nocpix Unveils ACE 2 Thermal Riflescope Lineup

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Silk Road Maritime Extends Its Global Reach in 2026

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...